ADAR1 Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELDN
ADAR1 Capital Management's ELDN Position: Q3 2026 in Review
ADAR1 Capital Management increased its Eledon Pharmaceuticals (ELDN) stake by 0.77% in Q3 2026, buying an estimated $16.8K and bringing the position to 652,812 shares worth $1.65M. The position accounts for 0.07% of the portfolio, ranked #156.
ADAR1 Capital Management first reported a position in ELDN in Q4 2024 and has held it in 7 quarters since. The position peaked at $3M in Q1 2026. 155 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.
- ADAR1 Capital Management held 652,812 shares of Eledon Pharmaceuticals worth $1.65M as of Q3 2026.
- ADAR1 Capital Management bought 5,000 Eledon Pharmaceuticals shares in Q3 2026, an estimated $16.8K.
- Eledon Pharmaceuticals made up 0.07% of ADAR1 Capital Management's portfolio in Q3 2026, its #156 holding.
- ADAR1 Capital Management first reported a position in Eledon Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- ADAR1 Capital Management's Eledon Pharmaceuticals position peaked at $3M in Q1 2026.
- 155 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.
Based on ADAR1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.